- Home
- SIF vs IGC Comparison
SIF vs IGC Comparison
Compare SIF & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- IGC
- Stock Information
- Founded
- SIF 1913
- IGC 2005
- Country
- SIF United States
- IGC United States
- Employees
- SIF N/A
- IGC N/A
- Industry
- SIF Office Equipment/Supplies/Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- IGC Health Care
- Exchange
- SIF Nasdaq
- IGC Nasdaq
- Market Cap
- SIF 15.8M
- IGC 18.0M
- IPO Year
- SIF N/A
- IGC N/A
- Fundamental
- Price
- SIF $2.57
- IGC $0.30
- Analyst Decision
- SIF
- IGC Strong Buy
- Analyst Count
- SIF 0
- IGC 2
- Target Price
- SIF N/A
- IGC $3.88
- AVG Volume (30 Days)
- SIF 3.4K
- IGC 261.6K
- Earning Date
- SIF 05-08-2025
- IGC 02-18-2025
- Dividend Yield
- SIF N/A
- IGC N/A
- EPS Growth
- SIF N/A
- IGC N/A
- EPS
- SIF N/A
- IGC N/A
- Revenue
- SIF $85,042,000.00
- IGC $1,236,000.00
- Revenue This Year
- SIF N/A
- IGC N/A
- Revenue Next Year
- SIF N/A
- IGC $18.34
- P/E Ratio
- SIF N/A
- IGC N/A
- Revenue Growth
- SIF 41.17
- IGC 1.65
- 52 Week Low
- SIF $2.33
- IGC $0.25
- 52 Week High
- SIF $5.96
- IGC $0.63
- Technical
- Relative Strength Index (RSI)
- SIF 44.60
- IGC 53.06
- Support Level
- SIF $2.38
- IGC $0.27
- Resistance Level
- SIF $2.66
- IGC $0.30
- Average True Range (ATR)
- SIF 0.13
- IGC 0.02
- MACD
- SIF 0.02
- IGC 0.00
- Stochastic Oscillator
- SIF 60.00
- IGC 69.74
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.